Infectious Diseases News and Research

RSS

Gene therapy shows potential against HIV

A new UCLA AIDS Institute study has found that gene therapy can be developed as a safe and active technique to combat HIV.

22 Feb 2009

MRSA infections in ICU patients have been decreasing in recent years

In contrast to the perception that methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections associated with use of a catheter is an increasing problem in intensive care unit (ICU) patients, the incidence of this type of infection decreased by nearly 50 percent from 1997 - 2007, according to a study in the February 18 issue of JAMA.

18 Feb 2009

Researchers show how immune system reacts to a hepatitis B infection

Researchers at the Helmholtz Centre in Braunschweig demonstrate how the immune system reacts to a hepatitis B infection.

17 Feb 2009

Weight loss improves nonalcoholic steatohepatitis

In a recent study, Saint Louis University researchers found that weight loss of at least 9 percent helped patients reverse a type of liver disease known as nonalcoholic steatohepatitis (NASH), a finding that will allow doctors to give patients specific weight-loss goals that are likely to improve their livers.

17 Feb 2009

Discovery of new mode of how diseases evolve

Researchers of the Michael G. DeGroote Institute for Infectious Disease Research have discovered a new way that bacteria evolve into something that can make you sick.

17 Feb 2009

Good bacteria may provide effective vehicle for an oral vaccine against anthrax

Researchers at North Carolina State University have discovered that the good bacteria found in dairy products and linked to positive health benefits in the human body might also be an effective vehicle for an oral vaccine that can provide immunity to anthrax exposure.

17 Feb 2009

U.S. Court of Federal Claims declares vaccines do not cause autism

The three judges ruled that the measles-mumps-rubella vaccine (MMR), given in combination with thimerosal-containing vaccines, does not cause autism.

17 Feb 2009

New software speeds enzyme design

A Duke University-led team has brought powerful software to the never-ending arms race between antibiotics and germs.

16 Feb 2009

Antimicrobial resistance in clinics, hospitals and at home

Antibiotic resistance and the rise of illnesses that cannot be treated easily because of drug resistance is a health concern around the world.

16 Feb 2009

Radioimmunotherapy shows promise for HIV infection and viral cancers

Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells.

16 Feb 2009

Researcher presents evolutionary history of modern humans in Africa

Sarah A. Tishkoff, PhD, David and Lyn Silfen University Associate Professor, will present "Evolutionary History of Modern Humans in Africa," at the 2009 American Association for the Advancement of Science (AAAS) annual meeting in Chicago, as a part of the Sunday, February 15th session, "Studying Vertebrate Genomes: Reading Evolution's Notebooks."

16 Feb 2009

Personal digital assistants used to track tuberculosis data

For patients who have drug-resistant forms of tuberculosis, it's critical to monitor the disease as closely as possible.

11 Feb 2009

5-in-1 combo vaccine increases on-time immunization in children

A "5-in-1" combination vaccine increases the percentage of children receiving all recommended vaccinations at the scheduled time, reports a study in the February issue of The Pediatric Infectious Disease Journal.

11 Feb 2009

Scientists identify protein key to Lyme disease

Researchers at UT Southwestern Medical Center have identified a protein that may help give Lyme disease its bite.

9 Feb 2009

Anti-HIV vaginal gel shows promise

An investigational vaginal gel intended to prevent HIV infection in women has demonstrated encouraging signs of success in a clinical trial conducted in Africa and the United States.

9 Feb 2009

Chemical mediator in blood found to also control breakdown of bone

A new study demonstrates that a chemical mediator in the blood that influences immune cell migration also plays a key role in maintaining the balance between the build-up and breakdown of bones in the body.

8 Feb 2009

Idenix Pharmaceuticals and GSK sign agreement for novel NNRTI for treatment of HIV

Idenix Pharmaceuticals, Inc. and GlaxoSmithKline (GSK) today announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899.

8 Feb 2009

Proof of concept vaccine against Chikungunya virus

Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen University, Erasmus University Medical Centre and Nobilon, a subsidiary of Schering-Plough, to develop a 'proof of concept' vaccine against the Chikungunya virus.

5 Feb 2009

Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

Sangamo BioSciences, Inc. has announced that its collaborators at the University of Pennsylvania have opened a Phase 1 clinical trial to evaluate SB-728-T for the treatment of HIV/AIDS.

5 Feb 2009

African-Americans aware and accepting, but often do not receive, the HPV vaccine

Although only 25 percent of eligible African-American adolescents have received the HPV vaccine, a new survey presented at the American Association for Cancer Research conference on the Science of Cancer Health Disparities, suggests they have a positive view of the treatment and might respond to more education.

5 Feb 2009